Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com

Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com




Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.

The publisher’s Medical Devices sector report, ‘Therapeutic Drug Monitoring Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update’ provides comprehensive information about the Therapeutic Drug Monitoring pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Therapeutic drug monitoring tests include reagents and test kits intended to measure different types of therapeutic drugs from samples ranging from serum/blood, urine, hair and sweat.

Scope

  • Extensive coverage of the Therapeutic Drug Monitoring under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Therapeutic Drug Monitoring and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Therapeutic Drug Monitoring under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Therapeutic Drug Monitoring Overview

3 Products under Development

3.1 Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

3.2 Therapeutic Drug Monitoring – Pipeline Products by Segment

3.3 Therapeutic Drug Monitoring – Pipeline Products by Territory

3.4 Therapeutic Drug Monitoring – Pipeline Products by Regulatory Path

3.5 Therapeutic Drug Monitoring – Pipeline Products by Estimated Approval Date

3.6 Therapeutic Drug Monitoring – Ongoing Clinical Trials

4 Therapeutic Drug Monitoring – Pipeline Products under Development by Companies

4.1 Therapeutic Drug Monitoring Companies – Pipeline Products by Stage of Development

4.2 Therapeutic Drug Monitoring – Pipeline Products by Stage of Development

5 Therapeutic Drug Monitoring Companies and Product Overview

6 Therapeutic Drug Monitoring- Recent Developments

7 Appendix

7.1 Methodology

7.2 About the Publisher

7.3 Contact the Publisher

7.4 Disclaimer

Companies Mentioned

  • 20/20 GeneSystems Inc
  • Abbott Diagnostics
  • Adaptive Biotechnologies Corp
  • Affinergy LLC
  • Animated Dynamics Inc
  • Applied Research using OMIC Sciences SL
  • ARK Diagnostics Inc
  • AutoGenomics Inc
  • Avacta Group Plc
  • BG Medicine Inc
  • BIOHOPE Scientific SL
  • Boston University
  • CCC Diagnostics LLC
  • Centre Hospitalier Universitaire de Nice
  • Chronix Biomedical Inc
  • Cognizance Biomarkers LLC
  • Columbia University
  • ContraVac Inc (Inactive)
  • Denovo Biolabs Pvt Ltd
  • DNAPrint Genomics Inc (Inactive)
  • Dublin City University
  • ELITechGroup Inc
  • Eurobio Scientific SA
  • Gene Express, Inc. (Inactive)
  • GenMark Diagnostics Inc
  • Horiba Ltd
  • Inflammatix Inc
  • Instrumentation Laboratory Co
  • Johns Hopkins University
  • KIYATEC Inc
  • Medibio Ltd
  • Medical Research Council
  • Metabolon Inc
  • Newcastle University
  • Nipro Europe N.V.
  • Nuclea Biotechnologies Inc. (Inactive)
  • Pax Neuroscience Inc
  • Pelago Bioscience AB
  • Pennsylvania State University
  • Plateletdiagnostics LLC
  • Prediction Sciences LLC (Inactive)
  • Progenika Biopharma SA
  • PrognosDx Health Inc
  • Proteomika (Inactive)
  • Purdue University
  • Queen Mary University of London
  • Roche Diagnostics Corp
  • Roche Diagnostics International Ltd
  • Rockland Immunochemicals Inc
  • SAGA Diagnostics AB
  • Saladax Biomedical Inc
  • Siemens Healthcare Diagnostics Inc
  • Sirius Genomics Inc
  • Spanish National Research Council
  • SQI Diagnostics Inc
  • T2 Biosystems Inc
  • TheraDiag SA
  • Thermo Fisher Scientific Inc
  • Universidade Feevale
  • University of Colorado
  • University of Colorado Denver
  • University of North Dakota
  • University of Queensland
  • University of Washington
  • Vyant Bio Inc

For more information about this report visit https://www.researchandmarkets.com/r/nxg2kr

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900